Clinical Trial

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study was to compare the efficacy, safety, and durability of two different strategies to treat participants with a history of sub-optimal adherence and control of their HIV infection: long-acting (LA) antiretroviral therapy (ART) and all-oral standard of care (SOC).
Protocol Amendment History 63 amendments
This ClinicalTrials.gov record has been amended 63 times since 2018-08-15; most recent amendment 2026-05-28.
Status change: Recruiting → Active, Not Recruiting 2024-08-15
Status change: Active, Not Recruiting → Recruiting 2020-07-24
Status change: Recruiting → Active, Not Recruiting 2020-04-06
Status change: Not Yet Recruiting → Recruiting 2019-03-29
Trial Details
NCT Number NCT03635788
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: ViiV Healthcare
Conditions HIV Infections
Enrollment 456 participants
Start Date 2019-03-28
Primary Completion 2024-02-12 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-24